Updated:
Shanghai Sinobioway Sunterra Biotechnology Co.
Shanghai Sinobioway Sunterra Biotechnology Co. is a China-based family office investing in biotechnology and real estate.
Shanghai Sinobioway Sunterra Biotechnology Co.
Shanghai Sinobioway Sunterra Biotechnology Co. is a firm based in Shanghai, China, with a focus on biotechnology and real estate. The entity shares its name with the Sinobioway group, a Chinese conglomerate active in biotech and agricultural sciences. Its founding year and principals are not publicly disclosed. Wealth origin is attributed to the broader Sinobioway group's operations in biotechnology and agriculture (public record). The firm's investment strategy centers on agricultural biotechnology, including crop science and food technology, alongside real estate development. It engages in direct investments and joint ventures, primarily within China. Sector coverage spans biotech research, AgriTech, and property projects. No named portfolio companies or co-investors are verifiable from public sources. Team size and additional offices are not publicly reported. No recent operational events from the last 24 months are available. The firm may maintain ties to Sinobioway's other ventures, but no philanthropic or adjacent vehicles are confirmed. A structural differentiator is the firm's dual focus on applied biotech and real estate, which is unusual among family offices—merging agricultural R&D with property development. This hybrid model may leverage land assets for both cultivation and real estate returns, but details are scarce.
General information
Firm type
Single Family Office
Year founded
—
AUM
Undisclosed
Location
Region
Asia
Country
China
City
Shanghai
Corporate office
Shanghai, China
Sector focus
Frequently asked questions
What is the investment focus of Shanghai Sinobioway Sunterra Biotechnology Co.?
The firm invests in agricultural biotechnology, including crop science and food technology, as well as real estate development. Its activities are centered on applied biotech research and land-based projects in China.
Is Shanghai Sinobioway Sunterra Biotechnology Co. a single family office?
Yes, it operates as a single family office, likely tied to the Sinobioway group, a Chinese conglomerate in biotechnology and agriculture. The entity focuses on direct investments and joint ventures in its sectors.
Does the firm disclose its AUM or investment performance?
No, the firm does not publicly disclose its assets under management, investment amounts, or performance figures. These details remain private.
What regions does Shanghai Sinobioway Sunterra Biotechnology Co. target?
The firm primarily invests in China, with a focus on the domestic market. No international investments have been publicly confirmed.
How does the firm's hybrid focus on biotech and real estate differ from typical family offices?
Most family offices specialize in either life sciences or real estate. This firm combines both, possibly integrating agricultural R&D with property development in China, which is a less common structural approach.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: